ALTERNATIVAS IMUNOTERAPÊUTICAS PARA O TRATAMENTO DA DOENÇA DE ALZHEIMER: AVANÇOS RECENTES E PERSPECTIVAS FUTURAS

Jeremic D, Jiménez-Díaz L, Navarro-López JD. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Research Reviews. 2021 Dec;72:101496;

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature [Internet]. 2016 Aug 31;537(7618):50–6. Available from: https://www.nature.com/articles/nature19323

Cardoso A, Bezerra L, Lima C, Bezerra I, Júnior J, Torres J (2022). Perpectivas atuais da terapia antiamiloide para a Doença de Alzheimer. Revista Neurociências. 30. 1-16. 10.34024/rnc.2022.v30.13552.

Jiaxuan L, Xin W, Xin T, Shixin W, Ruisi Q, Xiaofeng W, et al. The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis. Frontiers in Aging Neuroscience [Internet]. 2023 Nov 19 [cited 2023 Dec 11];1–12. Available from: https://web.s.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=5&sid=bbd1a48f-b5a1-47d1-9aa3-109ca3ea68fd%40redis;

Dantas JM, Mutarelli A, Navalha D, Dagostin C, Romeiro P, Félix N, et al. Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer’s disease: a systematic review and meta-analysis. Neurological Sciences. 2024 Jun;45(6):2461-2469.

Esquer A, Blanc F, Collongues N. Immunotherapies Targeting Amyloid and Tau Protein in Alzheimer’s Disease: Should We Move Away from Diseases and Focus on Biological Targets? A Systematic Review and Expert Opinion. Neurology and Therapy [Internet]. 2023 Dec;12(6):1883-1907. Available from: https://pubmed.ncbi.nlm.nih.gov/37812325/

Karimi N, Çatak FB, Arslan E, Saghazadeh A, Rezaei N. Tau immunotherapy in Alzheimer’s disease and progressive supranuclear palsy. International Immunopharmacology. 2022 Dec;113(Pt B):109445.

Zheng X, Tang YY, Yang Q, Wang S, Chen R, Tao C, et al. Effectiveness and safety of anti‐tau drugs for Alzheimer’s disease: Systematic review and meta‐analysis. Journal of the American Geriatrics Society. 2022 Oct 8;70(11):3281–92.

Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, et al. Pharmacotherapy of Alzheimer’s disease: is there a need to redefine treatment success? International Journal of Geriatric Psychiatry. 2001;16(7):653–66.